303 related articles for article (PubMed ID: 1846236)
1. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
[TBL] [Abstract][Full Text] [Related]
2. Live attenuated varicella vaccine use in immunocompromised children and adults.
Gershon AA; Steinberg SP; Gelb L
Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
[TBL] [Abstract][Full Text] [Related]
3. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
Hardy I; Gershon AA; Steinberg SP; LaRussa P
N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
[TBL] [Abstract][Full Text] [Related]
4. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
Gershon AA; Steinberg S; Gelb L; Galasso G; Borkowsky W; LaRussa P; Ferrara A
Postgrad Med J; 1985; 61 Suppl 4():73-8. PubMed ID: 3014482
[TBL] [Abstract][Full Text] [Related]
5. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
6. Live attenuated varicella vaccine: the KMcC strain in healthy children.
Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA
Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698
[TBL] [Abstract][Full Text] [Related]
7. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
8. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
[TBL] [Abstract][Full Text] [Related]
9. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of children with malignant disease against varicella.
Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
[TBL] [Abstract][Full Text] [Related]
11. [Active chickenpox vaccination of children with acute leukemia or other neoplastic diseases].
Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
Klin Padiatr; 1985; 197(6):477-80. PubMed ID: 3003449
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with Oka live varicella vaccine in Japan.
Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
15. [Varicella vaccination].
Heidl M; Scholz H
Padiatr Grenzgeb; 1990; 29(1):31-6. PubMed ID: 2160635
[TBL] [Abstract][Full Text] [Related]
16. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.
Watson BM; Piercy SA; Plotkin SA; Starr SE
Pediatrics; 1993 Jan; 91(1):17-22. PubMed ID: 8416499
[TBL] [Abstract][Full Text] [Related]
17. A review of the varicella vaccine in immunocompromised individuals.
Sartori AM
Int J Infect Dis; 2004 Sep; 8(5):259-70. PubMed ID: 15325594
[TBL] [Abstract][Full Text] [Related]
18. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
[TBL] [Abstract][Full Text] [Related]
19. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
[TBL] [Abstract][Full Text] [Related]
20. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
Brunell PA; Geiser CF; Novelli V; Lipton S; Narkewicz S
Pediatrics; 1987 Jun; 79(6):922-7. PubMed ID: 3035478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
